Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

BACKGROUND: More accurate risk assessments are needed to improve prostate cancer management. OBJECTIVE: To identify blood-based protein biomarkers that provided prognostic information for risk stratification. DESIGN, SETTING, AND PARTICIPANTS: Mass spectrometry was used to identify biomarker candida...

Descripción completa

Detalles Bibliográficos
Autores principales: Guldvik, Ingrid J., Zuber, Verena, Braadland, Peder R., Grytli, Helene H., Ramberg, Håkon, Lilleby, Wolfgang, Thiede, Bernd, Zucknick, Manuela, Saatcioglu, Fahri, Gislefoss, Randi, Kvåle, Rune, George, Anne, Grönberg, Henrik, Wiklund, Fredrik, Neal, David E., Gnanapragasam, Vincent J., Taskén, Kristin A., Mills, Ian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317831/
https://www.ncbi.nlm.nih.gov/pubmed/34337468
http://dx.doi.org/10.1016/j.euros.2020.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317831/
https://www.ncbi.nlm.nih.gov/pubmed/34337468
http://dx.doi.org/10.1016/j.euros.2020.08.007

Ejemplares similares